Drug Shortage Report for MYLAN-VERAPAMIL
Report ID | 88302 |
Drug Identification Number | 02237922 |
Brand name | MYLAN-VERAPAMIL |
Common or Proper name | VERAPAMIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
Strength(s) | 120MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 BT |
ATC code | C08DA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-07-02 |
Estimated end date | 2019-10-18 |
Actual end date | 2019-10-15 |
Shortage status | Resolved |
Updated date | 2019-10-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2019-10-16 | English | Compare |
v10 | 2019-10-15 | French | Compare |
v9 | 2019-10-15 | English | Compare |
v8 | 2019-09-17 | French | Compare |
v7 | 2019-09-17 | English | Compare |
v6 | 2019-09-03 | French | Compare |
v5 | 2019-09-03 | English | Compare |
v4 | 2019-07-23 | French | Compare |
v3 | 2019-07-23 | English | Compare |
v2 | 2019-07-03 | French | Compare |
v1 | 2019-07-03 | English | Compare |
Showing 1 to 11 of 11